Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL34742

C[n+]1ccn(CCCS(=O)(=O)O)c1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
APAF1 O14727 1/20 0.43
NPC1 O15118 1/20 0.43
PLA2G1B P04054 1/20 0.43
HSP90AA1 P07900 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
FDPS P14324 8/20 0.37
KCNH2 Q12809 6/20 0.32
LMNA P02545 1/20 0.32
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL34312 0.96 SMN1; SMN2 (0.46) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL34601 0.89 SMN1; SMN2 (0.47) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL16934856 0.89 SMN1; SMN2 (0.53) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL18260148 0.87 SMN1; SMN2 (0.51) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Sulfuric Acid SCHEMBL12544525 0.86 SMN1; SMN2 (0.51) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL318471 0.85 MEN1 (0.52) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL14973961 0.85 SMN1; SMN2 (0.48) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL29390371 0.85 MEN1 (0.58) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL34897 0.85 SMN1; SMN2 (0.50) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL294105 0.85 MEN1 (0.58) SMN1; SMN2MEN1APAF1NPC1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114524797-B Synthetic method of benzothiophene 华中科技大学 2023-03-10 CN claimed
CN-114524797-A Synthetic method of benzothiophene 华中科技大学 2022-05-24 CN claimed
CN-114524797-B Synthetic method of benzothiophene 华中科技大学 2023-03-10 CN disclosed
CN-114524797-A Synthetic method of benzothiophene 华中科技大学 2022-05-24 CN disclosed
EP-2473277-B1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION OR ACID-FUNCTIONALIZED IONIC LIQUID UNIV DENMARK TECH DTU (DK) 2019-07-03 EP disclosed
US-20170341067-A1 Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid UNIV DENMARK TECH DTU (DK) 2017-11-30 US disclosed
US-20110065950-A1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID TECHNICAL UNIVERSITY OF DENMARK (DK) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065950-A1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID PDCD2L, PCCA, PDK2 SMN1; SMN2 2392/4885MEN1 1283/4885APAF1 3773/4885
US-20170341067-A1 Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid PDCD2L, PCCA, PDK2 SMN1; SMN2 2392/4885MEN1 1283/4885APAF1 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.